Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - NEUROLOGIX INC/DE | v221904_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 13, 2011
Neurologix, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Delaware
|
000-13347
|
06-1582875
|
||
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
One Bridge Plaza, Fort Lee, New Jersey
|
07024
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (201) 592-6451
|
(Former Name or Former Address, if Changed Since Last Report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
On May 13, 2011, Neurologix, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2011. A copy of the press release is furnished herewith as Exhibit 99.1 to this report and hereby incorporated by reference.
The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Press release of Neurologix, Inc., dated May 13, 2011 (furnished pursuant to Item 2.02 of Form 8-K).
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
NEUROLOGIX, INC.
|
||
|
|
||
|
Date: May 13, 2011
|
By: /s/ MARC L. PANOFF
|
|
|
Name: Marc L. Panoff
|
||
|
Title: Chief Financial Officer, Secretary and Treasurer
|
EXHIBIT INDEX
|
Exhibit
|
Description
|
|
|
99.1
|
Press Release of Neurologix, Inc., dated May 13, 2011 (furnished pursuant to Item 2.02 of Form 8-K).
|